We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


GeneNews Diagnostics Launches ColonSentry in Malaysia

Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "GeneNews Diagnostics Launches ColonSentry in Malaysia"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

GeneNews Limited has announced the commercial launch of ColonSentry™, the world's first blood-based test to determine a person's current risk for colorectal cancer, in Malaysia through GeneNews Diagnostics Sdn. Bhd.

The formal launch ceremony was officiated by Y'B Senator Tan Sri Dr. Koh Tsu Koon, a Minister in the Malaysian Prime Minister's Department.

"We are excited that GeneNews Diagnostics will now be able to provide the Malaysian population with access to this potentially life-saving colorectal cancer pre-screening tool. We also believe that commercial success in Malaysia, a key country in the Southeast Asian market, will help facilitate the commercial expansion of the ColonSentry test throughout this part of the world", said Gailina J. Liew, President and Chief Operating Officer of GeneNews.